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Psoriasis is a common autoimmune skin condition affecting 2-4% of the worldwide 
. po~ulation. It is common practice for nurses who do not specialize in the field of 
:dermatology taking care of patients with psoriasis as primary or secondary condition. 
"'fhi,s guide serves as a helpful tool for nurses. It provides information regarding psoriasis' 
·;+physiological features, risk factors, treatment, and expected adverse effects. 
··Psychological aspect of living with psoriasis on a day-to-day basis and effect it can have 
on qualityof life are also addressed. Lastly, additional resources.are<listed for nurses' 
andpatients' use. 
By Elena Segev, BA 
Sandra Restaino, DNP, FAANP 
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Introduction to Psoriasis 
Psoriasis is one of the most common autoimmune chronic conditions with 2-
4% of worldwide population suffering from it. It is typical to all ethnicities, 
races, ages, and sexes. 
It is caused by abnormally fast skin cells proliferation which is mediated by 
extremely reactive T-helper 17 (Th17) white blood cells and probably 
related to angiogenesis (new blood vessels formation). It is believed to have 
genetic predisposition. 49% of the patients have first degree relatives with 
the disease. As much as 75% prevalence has been found in monozygotic 
twins. A dominant allele is the related genetic component. Different 
ethnicities have different gene for psoriasis singled out. 
The exact trigger for psoriasis is unknown but it is associated with extreme 
stress, alcohol consumption, certain diseases (streptococcal infections, 
Crohn's disease), metabolic syndrome, and some medications. 
This is a lifelong condition with no cure and is a truly human disease that is 
not found in animals. This is why psoriasis is hard to mimic on laboratory 
animals, which make a research more complicated. Symptom management is 
the only current option for patients with psoriasis. 
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Pathophysiology 
Psoriasis is a chain ofhyperimmune reactions. Leukocytes Langerhans cells and 
Thl7 cells release inflammatory cytokines as a reaction to a certain trigger. 
Angiogenesis seems to promote those inflammatory reactions but also 
streptococcal bacteria and physical damage. Inflammatory agents like tumor 
necrosis factor (TNF-a), interleukins (IL) IL-23, IL-17, and interferon- y lead to 
continuous over-reaction that causes an uncontrollable keratinocyte proliferation. 
The usual cell's lifecycle of28 days shortens instead to four days. 
It is diagnosed based on the gross features and family history of psoriasis. One of 
the most common tools used to assess severity of the disorder is Psoriasis Area and 
Severity Index (PASI) with rating 0 to 4, four being the most severe. Helpful links 
are cited in the resources section. 
Psoriasis is known to have a few related comorbidities. It includes psoriatic 
arthritis, cardiovascular diseases, diabetes, skin infections, and various 
psychological problems from distorted body image to depression. 
Th17/ymphocytes and psoriasis: Th17 interact with immune cells, primarily dendritic cells 
and fibroblasts residing in skin that trigger psoriatic reaction of keratinocytes (KS) 
proliferation. 
Image from JOurnal of Investigative Dermatology 
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Types of Psoriasis 
Plaque psoriasis 
Most common type of psoriasis with distinguished 
gross features. The most studied form. 
Guttate psoriasis 
Typical in children, onset usually indicates plaque 
psoriasis in adulthood. 
Pustular psoriasi!' 
Relatively rare psoriasis.Generalized pustular 
psoriasis: rapid spread of inflamed skin patches, 
accompanied whhpain,Jever, and s· . . 
I lymphadenopathy; Potentially life threatening du~ .to 
I 
its_d.e.manding effect onthe.cardio"vascular and 
. unnary systems. · 
. ; Erythmdermic psoriasis 
I 
Rare form of psoriasis. Erythema with severe 
itching, pain, and scaling. Weakened immune 
system makes a patient vulnerable toinfections, 
compromised body temperature homeostasis, and 
chemical balance disruption. 
Other forms of psoriasis 
<~~ Inverse psoriasis (in skin folds) 
<~~ Palmar (hand) psoriasis 
• .Plantar (foot) psoriasis 
<~> Nailfold.psoriasis. 
<~> · Facial psoriasis 
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Comorbidities 
Patients with psoriasis are more likely to have or develop additional health conditions. Such 
conditions include but not limited to: 
Psoriatic arthritis: About 10% of psoriasis patients develop arthritis related to psoriatic 
inflarmnatory reactions. This problem is especially overlooked in children if not reported. 
Assess your patient for acute or chronic joint pain. 
Cardiovascular diseases aud conditions: In recent years psoriasis is ·seen by the 
specialists as an independent risk factor for developing cardiac conditions as myocardial 
infarction and stroke and vascular diseases like peripheral vessels blood flow resistance, 
cerebrovascular damage, and occlusive vascular disorders. Pay very close attention to the 
patient's cardiovascular status. Blood pressure screening and cardiac function assessment 
should be a priority. 
Crohn's disease: Many researchers see a connection between both disorders. There is 
strong evidence that the same gene is responsible for both. Assess for gastrointestinal tract 
function, quality of stool, bowel movement, pain, and other signs and symptoms related to 
Crohn 's disease. 
Diabetes mellitus: Although there is no strong support that psoriasis causes DM, many 
studies show that patients with psoriasis in general have higher rates of DM than general 
population. Blood glucose and symptoms of diabetes should be a routine during annual 
physical checkup for early detection. 
Depression: Burden of a deforming disease can take toll on the mental status of the patient 
with psoriasis. Do not forget to ask questions related to quality of life, mood, and self-
image. Prevention and treatment of depression is a very important step in successful 
disease management. 
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Treatment of Psoriasis 
Traditional Methods 
Treatment 
Corticosteroids/ 
Retinoids/ 
Vitamin D analogs 
Topical Agents 
Phototherapy 
Systemic Agents 
Description 
Steroid induced ointment, 
first line treatment for newly 
diagnosed and mild cases of 
psoriasis by weakening 
immune reaction and slowing 
down cells growth.,. 
Ultraviolet light B (UVB) and 
Psoralen Ultraviolet A 
(PUV A). Penetrates skin, 
slows down keratinocytes 
growth, and eradicates old 
tissue. One of the most 
effective symptom 
management. 
Same mode of action as UVB 
only from the sun. Some 
geographical points of earth 
present perfect conditions for 
safe UVB penetration. Those 
poits are the Dead Sea, 
Balneo, Italy, many points in 
Poland and more. 
Systemic drugsthat act on . 
immune system. Include 
methotrexate (Trexall), 
cyclosporine (Restasis ), oral 
retinoids. 
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Considerations 
Due to tissue thinning effect cannot be 
used for long periods of time. Apply 
carefully within a lesion border to 
avoid healthy cells destruction. 
Limited to mild and moderate cases. 
Retinoid. and Vitamin D can be 
teratogenic. 
Performed in clinical setting. May 
alleviate symptoms (itching, redness) 
before clearing begins. 
A few studies warn about potential for 
skin cancer. Urge patients to follow up 
with dermatologist after treatment 
PUV A is considered a higher risk for 
skin cancer developinent. 
In general any sun exposure of psoriatic 
skin is beneficial. 
Avoid overexposure. Recommend 
gradual increase exposure time. Consult 
doctor about plarming. Results might 
not be inm1ediate; 2-4 weeks may be 
needed before the improvement. 
·Immunosuppressant. Watch for 
opportunistic infections. Supplement 
diet with folate .. Extremely teratogenic. 
'Biologic Agents· · For treatment of moderate to Systemic immtmosuppressive. Pay 
severe psoriasis. Monoclonal close attention to infections. Educate 
antibodies suppress immune about immunosuppression precautions 
reaction reversing psoriasis such as avoiding crowded places, 
symptoms. Includes brands immunization, hand hygiene, 
adalimumab (Humira), immediate attention from the healthcare 
etanercept (Enbrel), professional if infection signs occur 
:;:m"h (Rcmi"<!o), ~.d ···I (f"" red"'"· ~lli,g) 
Experimental Methods 
;;'Treatment 
'+ 
Genetic Therapy 
RroteinTherapy 
Description 
Certain foods are found to improve 
,symptoms or to alleviate. thern. 
{Favorable groups incl:ude fish, • 
" ;Iamb, fruits, vegetables ( excep(~' 
tomatoes/eggplants, and peppers);' 
whole grains, and nuts. 
1 A corrected gene is being inserted 
into the skin cell and replaces 
genetic material by mitosis. 
Insertion via micro-needles and 
electric bean1. 
A new specific protein has been 
. singled out in 2012. The protein 
located on gene REG3A has 
shown a strong correlation to 
psoriasis and has ·a potential to 
·become a new target for evolving 
treatments •. 
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Considerations 
Studies are very limited and 
inconsistent. Some general 
suggestions can be suggested for 
·healthy lifestyle. Alcohol 
·consumption worsens symptorns. 
Experimental studies performed 
on mice. Not sate as there is no 
studied bng tenn or adverse 
eflects. No human trial has been 
performed. 
No studies have been performed 
for such treatment. The discovery 
lays a ground for the future 
explorations. 
Special Demographics: Children and Adolescents 
It is important for nurses to understand that direct involvement in child's care has 
its impact on quality on family dynamics. Those families usually have restricted 
social activities or cancelled trips due to scheduled or long term treatments. 
Depression, frustration, emotional stress, concerns, anxiety due to lack of control 
over child's disease and knowledge of its lifelong effect are very common in those 
families. Financial burden because of treatment expenses also should be considered 
as many of the treatments are expensive. 
Family assessment is as important as the child carrying this condition. Carefully 
listen to the child's and parents' concerns. School and society in general present a 
great potential for increased peer pressure, bullying, and rejection due to 
expressive features of psoriasis. Kids feel ashamed, stared at, and marked as 
contagious. Such a state is a risk factor for developing early signs of depression. 
A successful assessment will find the information about current treatment, 
difficulties in treatment (side effects, schedule, costs), presence of social pressure 
(such as teasing, bullying, staring), body image status, access to information and 
services, emotional status for depression or suicidal ideations, and active 
participation in a support group or counseling. It is also important to reinforce the 
education regarding the treatments, especially these with severe side effects, and 
continue monitoring physiological and psychological status. 
Family: grief and 
;struggle 
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. 
Friends: body 
image 
Treatment: side 
, effects , 
. 
Special Demographics: Pregnant Women 
As any other chronic disease, psoriasis in pregnancy presents certain risks for 
negative outcomes. Certain complication related to the course of the disease are 
being detected and reported. There is also a strong evidence for the positive impact 
of pregnancy on psoriasis. Below is a summary of potential outcomes and proper 
handling of those cases. Generally, psoriasis is not considered a serious threatening 
condition to a future mother by the healthcare personnel and tllis information can 
be easily overlooked. Importance of asking the patient relevant questions is 
unquestionable. Education about those risks is equally important. 
Psoriatic, Flares 
~qhronic Hypertension 
R,ecurring' 
Spontaneous · 
Abortions, 
Cesarean Section 
Psoriasis Management 
General improvement of the skin condition from 10 to 20 
weeks of pregnancy due to high maternal blood estrogen. 
However, about 90% of the patients will develop flares within< 
6 weeks postpartum. 
Educate the patient regarding expected worsening of the 
symptoms. 
Consistent evidence that pregnant women with psoriasis are 
more likely to develop chronic hypertension. Blood pressure 
screening and potential management are vital as hypertension, 
can lead to severe complications including fatal outcome. 
As with hypertensions, psoriasis puts pregnant women at 
higher risk for spontaneous abortions. Obtain history of 
previous pregnancies in order to detennine thisrisk. 
Psoriasis presents as an independent risk factor for .caesarian 
delivery. 
First line: topical corticosteroids and emollients 
Avoid: coal tar and vitamin D-like substances. Not enough 
evidence for their safety 
Second line: UVB. 
Must be avoided due to teratogenicity: oral and topical 
retinoids (related to vitamin A), methotrexate,'calcipotriol 
derivatives. 
Biological agents did not show tetragenicity but their effect on 
pregnancy is unknown. Take precaution dirring severe 
psoriasis flares. 
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Special Demographics: Surgical and Acute Patients 
There is a split of opinion between dermatologists and surgical specialists regarding 
operational incisions on patients with active psoriasis. Dermatologists in general do 
not see any contraindications for cutting psoriasis covered skin. Sergeants, on the 
other hand, tend to oppose such practices due to increased risk of infections. The 
tendency is to treat active psoriasis before the elective procedure. There is very 
limited research in this area and the table below summarizes some possible known 
scenarios on acutely ill patients with comorbid psoriasis. 
Surgery on active 
psoriatic skin 
Psoriasis treatment initiation prior to a surgery isrecommended to 
avoid infection complications. 
If the surgery is urgent increased dose antibiotics and 
corticosteroid therapy immediately after surgery is anticipated. 
Usually sergeants will notperform an incision longer than 30cm 
on psoriatic skin. However, ther'( is evidence that such incisions 
do not necessarily cause further complications. 
---~--~-~-----~--~~~---~--~~~~~--~~--;Post-Surgical The skin with psoriasis is a favorable environment for 
fPatients with_ opportunistic microorganisms. 
Nosocomial Use of silver induced dressing showed a significant improvement 
--Infections up until complete healing of postsurgical wounds complications. 
- One case study presented a complication on a patient with 
lmmunocompromised 
patients and patients -
with HIV ---
psoriasis whq underwent an orthopedic surgery and acquired 
methicillin resistant Staphylococcus aureus (MRSA). The client 
was completely cleared with silver covered dressing after many 
mollths of unsuccessful antibiotic treatment and traditional 
dressing. 
Treatment with biologic and systemic agents, especially with 
mycophenolate is highly recommended. _-
Study shows that patients with weakened immune system such as 
organ transplant patients and human immunodeficiency'virus 
(HIV) infected clients show positive results with-use ofthis 
- treatment. 
f~~-----~~~~~~,--~~~~-----------~~~--~~~~ Koebner• New pathological lesions development at the site of surgical 
-(isomorphic) procedures or other traumas on clear skin in patients with 
phenomenon psoriasis or other cutaneous conditions. A response to 
- mechanical or thermal trauma, dermatoses, allergic reactions, 
therapies like iodine application or ultraviolet light and' other 
interventions. _ _ -
Pay close attention to new formation in postoperative/traumatic 
patients. 
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Psychological Aspect 
Distorted body image: most of the psoriasis patients feel unclean and messy due 
to constant flaking of the skin. This adds to reduction of quality of everyday life. 
Many patients also feel that they are being stared at by strangers. 
Shame and uncertainty: The vast majority of the psoriasis clients make efforts to 
cover psoriasis expression to avoid an unwanted attention to their condition. In 
some cases they cover and hide it from their families, spouses or even physician. 
Asking appropriate questions and expressing non-judgmental attitude is key. 
Stigmatization and bullying: Most of the patients are convinced that general 
public sees psoriasis as a contagious disease. It is more prominent in teenagers and 
younger adults who are subjected to unrealistic body image standard promoted by 
the media and society. Bullying increases chances for distorted body image and 
personal unworthiness. The severity ofthe symptoms correlated to the low self-
esteem, and lower quality of life, especially in women. Pay close attention to the 
patient's needs and discuss psychological status as a part of assessment. 
Relationship management: Severe psoriasis symptoms become a challenge or 
even an obstacle in relationship for both men and women suffering from psmiasis. 
Some of them even go through rejection due to their appearance. Studies show that 
patients with psoriasis are more fearful to engage in sexual relationships due to 
distorted self-image. 
Stress: About half of psoriasis patients experience increased stress level due to 
exacerbation episodes. Such a reaction would trigger even more severe psoriatic 
response causing even more stress. It is important to recognize if this vicious circle 
exists in your patient's life. 
Harmful lifestyles! It is also found that many psDriasis patients are likely to 
engage in self-destructive behaviors like binge eating, substance abuse and 
unprotected sexual contact. There is a correlation between personal belief in 
symptom management and treatment and harmful behavior. Addressing those 
issues during the formal assessment is an important step for improving quality of 
life. 
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Lifestyle Alterations 
Symptom management: Follow the treatment regimen closely. Use emollients for itch 
control; manage a diary of the flare outbreaks to find a pattern and triggers. 
Avoidance of known triggers: Prevent streptococcal infections, avoid severe stress. 
Infection control: Avoid large crowds, especially during infectious outbreaks, hand 
hygiene, inspect flared sites for signs of infections, seek immediate attention if new lesions or 
suspicious formations appear. Be especially vigilant after invasive medical procedures. 
Healthy lifestyle: Smoking cessation, limited alcohol consumption, balanced diet, active 
lifestyle and hydration are highly encouraged. Avoid synthetic tight clothing or wool- they can 
cause itch. Reduce consumption of foods with inflanunatory properties like animal protein and 
fat. 
Stress reduction: Use relaxation techniques like meditation, deep breathing, muscle 
relaxation, guided imagery, and counseling. Develop coping plan with your therapist. Utilize 
local or online support groups. 
Self-perception: Think positive. Wear comfortable, loose-fitting clothes. Avoid dark 
colors as they make skin flakes too visible. Carry emollients with you. Do not avoid sun: the sun 
is an excellent source for UVB which is beneficial for psoriasis management. Tight clothes also 
can cause excessive sweating, which alleviates symptoms. Do not be afraid of talking about your 
condition; people are more likely to understand if you are open about it. 
Managing relationships: Discuss your fears, concerns, and experience with your family 
and friends. Try to be as clear as possible about your experience in order for them to understand 
your frustration. Do not blame them but rather let them participate in your routine. Do not limit 
social interaction. 
Adjustment to social interaction: Create a support circle. Be open with your 
management about your condition and request accommodations if needed. Be organized with 
your doctor appointments; discuss the issue with management to find appropriate arrangements. 
Up to date education: Keep up with the most recent findings and researches. Do not skip 
doctor appointments. Subscribe to newsletter services from National Psoriasis Foundation or 
other organizations. Drug companies producing psoriasis medications also have access to most 
recent updates on condition's fmdings. 
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Resources 
Resources for nursing education: 
Agency for Healthcare Research and Quality (AHRQ): 
http://www.guideline.gov/content.aspx?id=38575&search=psoriasis 
Medline Plus: http:/ /www.nlm.nih.gov/medlineplus/psoriasis.html 
PAS! assessment tool: http://www. pasitraining.com/ calculator/ step _1. php 
Resources for patients and their families: 
International Federation of Psoriasis Associations (IFPA): http://www.ifpa-
pso.org/ 
National Psoriasis Foundation: www.psoriasis.org 
Place for !.:ids with psoriasis: www.PsoMe.org 
Psoriasis Cure Now: http://www.psoriasis-cure-now.org/ 
Psoriasis ~'Jeaks: http://www.psoriasis.com/?cid=ppc _ppd _ hderm _ggl_ 041021 
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